Summary
See this important discussion on the challenges and opportunities for patients with radiographic progressive disease, including a look at the tools and evidence available to practitioners to address specific patient needs. This program also includes a review of the latest prospective outcomes documenting the efficacy of laser interstitial thermal therapy (LITT) for biopsy proven radiation necrosis, the value of early biopsy for these patients, and where LITT fits in the treatment spectrum.
Highlights/Chapters
Background – Dr. Chan
The challenge of managing radiographic progression – Dr. Chan
Benefits & Drawbacks of current treatments for post-SRS progression – Dr. Strowd
Evidence of LITT for biopsy proven RN – Dr. Chan
Benefits of early intervention – Dr. Laxton
Clinical Evidence Opportunity – Dr. Laxton
How we employ SRS in the future – Dr. Chan
Discussion & Questions – Panel
Presenter: Roy Strowd III, MD; Michael Chan, MD; Adrian Laxton, MD
Conditions: Brain Tumors; Primary; High Grade Glioma; Low Grade Glioma; Recurrent Glioma; Other; Metastasis; Radiation Necrosis; Progressive; Upfront
AA10820-11